TITLE

FDA Gives GSK Angst on Paxil

AUTHOR(S)
Edwards, Jim
PUB. DATE
March 2005
SOURCE
Brandweek;3/7/2005, Vol. 46 Issue 10, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the action taken by the U.S. Food and Drug Administration (FDA) to seize supplies of GlaxoSmithKline (GSK) drugs, anxiety/depression treatment Paxil CR and diabetes treatment Avandamet as of March 7, 2005. Locations of the raids; Failure of the pills to meet the FDA standards; Comment from GSK representative Bernadette King about the advertisements for the seized products.
ACCESSION #
16440878

 

Related Articles

  • Type 2 Drug Seized.  // Diabetes Health;May2005, Vol. 14 Issue 5, p23 

    Reports on the seizure of oral diabetes medication Avandament and antidepressant Paxil CR from GlaxoSmithLkine in the U.S. in 2005. Reason behind the seizure; Views of the U.S. Food and Drug Administration on the drugs.

  • DDMAC TELLS GLAXO.  // Medical Marketing & Media;Oct2001, Vol. 36 Issue 10, p38 

    Reports the request of the U.S. Food and Drug Administration to cease the direct-to-consumer broadcast and print advertising of GlaxoSmithKline for diabetes treatment.

  • FDA Demands to be the Final Authority. Wechsler, Jill // Pharmaceutical Executive;Oct2002, Vol. 22 Issue 10, p33 

    Reports developments related to drug advertising in the U.S. as of October 2002. Effects of anti-smoking therapies on pregnant women; Creation of rulings involving drug labeling and advertising; Derivation of television advertising claims for Paxil from GlaxoSmithKline PLC.

  • Tami-Fakes. Herper, Matthew // Forbes Asia;2/13/2006, Vol. 2 Issue 2, p18 

    The article presents information on the seizure of shipments of pills ordered online in San Francisco, California in December 2005. The confiscated pills were labeled as generic Tamiflu and has been high in demand because it could help contain a bird flu pandemic. The U.S. Food & Drug...

  • FDA getting tougher. Colford, Steven W. // Advertising Age;4/29/1991, Vol. 62 Issue 18, p1 

    Reports on the seizure of a number of Citrus Hill Fresh Choice orange juice of Procter & Gamble Co. by the U.S. Food & Drug Administration (FDA). Significance of the seizure; Statement from FDA Commissioner David Kessler; Reaction from several food companies.

  • N.J. company's IMDs seized due to manufacturing deficiencies.  // Medical Device Daily;4/19/2007, Vol. 11 Issue 75, p3 

    The article reports on the seizure of all implantable medical devices from Shelhigh by U.S. marshals and the investigators of the U.S. Food and Drug Administration (FDA). According to the FDA, there were significant deficiencies in the company's manufacturing processes. The agency needs all...

  • Dental devices seized.  // Medical Device Daily;1/14/2011, Vol. 15 Issue 10, p8 

    The article reports on the seizure by U.S. marshals of dental devices from Rite-Dent Manufacturing. According to the Food and Drug Administration (FDA), the seizure involved the confiscation of products valued at around 209,000 U.S. dollars. It notes that the action came after an inspection...

  • Contaminated Honey Seized.  // FDA Consumer;May/Jun2003, Vol. 37 Issue 3, p6 

    Reports the seizure of contaminated imported honey by U.S. Marshals at the request of the Food and Drug Administration. Background on the contaminant chloramphenicol.

  • FDA Seizes Drugs Manufactured by Caraco in Michigan. Ramesh, Deepti // Chemical Week;7/6/2009, Vol. 171 Issue 18, p45 

    The article reports on the seizure by U.S. marshals of drug products manufactured by Caraco Pharmaceutical Laboratories at Caraco's facilities in Detroit, Farmington Hills, and Wixom, Michigan. The seizure was mandated by the U.S. Food and Drug Administration (FDA) following Caraco's continued...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics